Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases.

The pathogenic origin of autoimmune diseases can be traced to both genetic susceptibility and epigenetic modifications arising from exposure to the environment. Epigenetic modifications influence gene expression and alter cellular functions without modifying the genomic sequence. CpG-DNA methylation, histone tail modifications and microRNAs (miRNAs) are the main epigenetic mechanisms of gene regulation. Understanding the molecular mechanisms that are involved in the pathophysiology of autoimmune diseases is essential for the introduction of effective, target-directed and tolerated therapies. In this review, we summarize recent findings that signify the importance of epigenetic modifications in autoimmune disorders while focusing on systemic lupus erythematosus. We also discuss future directions in basic research, autoimmune diagnostics and applied therapy.

[1]  Mariana J. Kaplan,et al.  Demethylation of Promoter Regulatory Elements Contributes to Perforin Overexpression in CD4+ Lupus T Cells1 , 2004, The Journal of Immunology.

[2]  Moncef Zouali,et al.  Epigenetics in lupus , 2011, Annals of the New York Academy of Sciences.

[3]  J. S. Godde,et al.  Cracking the enigmatic linker histone code. , 2007, Journal of biochemistry.

[4]  A. Pasquinelli,et al.  Genes and Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal RNAs that Control C. elegans Developmental Timing , 2001, Cell.

[5]  G. Tsokos,et al.  Methylation Status of CpG Islands Flanking a cAMP Response Element Motif on the Protein Phosphatase 2Acα Promoter Determines CREB Binding and Activity1 , 2009, The Journal of Immunology.

[6]  Robert E. Lewis,et al.  HLA DRB1*1503 allelic haplotype predominance and associated immunodysregulation in systemic lupus erythematosus. , 2011, Experimental and molecular pathology.

[7]  Q. Lu,et al.  Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. , 2010, Arthritis and rheumatism.

[8]  C. Hedrich.  Genetic Variation and Epigenetic Patterns in Autoimmunity , 2011 .

[9]  M. Nambiar,et al.  Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: A new mechanism for TCR ζ chain deficiency and abnormal signaling * † , 2002, Journal of cellular biochemistry.

[10]  U. Müller-Ladner,et al.  Rheumatoid arthritis progression mediated by activated synovial fibroblasts. , 2010, Trends in molecular medicine.

[11]  P. Dieudé.  Rheumatic diseases: environment and genetics. , 2009, Joint, bone, spine : revue du rhumatisme.

[12]  Y. Liu,et al.  Stimulatory and Inhibitory Killer Ig-Like Receptor Molecules Are Expressed and Functional on Lupus T Cells1 , 2009, The Journal of Immunology.

[13]  Alain Saraux,et al.  IL-6 Modulates CD5 Expression in B Cells from Patients with Lupus by Regulating DNA Methylation1 , 2009, The Journal of Immunology.

[14]  Jing Wang,et al.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.

[15]  Q. Lu,et al.  MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. , 2011, Arthritis and rheumatism.

[16]  M. Lindsay,et al.  microRNAs and the immune response. , 2008, Trends in immunology.

[17]  S. Muller,et al.  Epigenetic Histone Code and Autoimmunity , 2010, Clinical reviews in allergy & immunology.

[18]  R. Gay,et al.  DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. , 2009, Arthritis and rheumatism.

[19]  R. Gay,et al.  Epigenetic control in rheumatoid arthritis synovial fibroblasts , 2009, Nature Reviews Rheumatology.

[20]  K. M. Pauley,et al.  Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren's syndrome before disease onset , 2009, Immunology and cell biology.

[21]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[22]  R. Read,et al.  Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[23]  S. Muller,et al.  Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[24]  G. Tsokos,et al.  B cells contribute to ischemia/reperfusion-mediated tissue injury. , 2009, Journal of autoimmunity.

[25]  E. Heard,et al.  X inactivation and the complexities of silencing a sex chromosome. , 2009, Current opinion in cell biology.

[26]  F. Fuks,et al.  A methylation rendezvous: reader meets writers. , 2007, Developmental cell.

[27]  Q. Lu,et al.  Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice , 2009, Scandinavian journal of rheumatology.

[28]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[29]  G. Hannon,et al.  Processing of primary microRNAs by the Microprocessor complex , 2004, Nature.

[30]  J. Harley,et al.  Recent insights into the genetic basis of systemic lupus erythematosus , 2009, Genes and Immunity.

[31]  J. Haines,et al.  Genetics and pathogenesis of multiple sclerosis. , 2009, Seminars in immunology.

[32]  D. Levy,et al.  Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation1 , 2009, The Journal of Immunology.

[33]  P. Meroni,et al.  Updating on the pathogenesis of systemic lupus erythematosus. , 2010, Autoimmunity reviews.

[34]  T. Thai,et al.  Is there a link between dysregulated miRNA expression and disease? , 2010, Discovery medicine.

[35]  Yuanjia Tang,et al.  MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. , 2010, Arthritis and rheumatism.

[36]  R. Shiekhattar,et al.  The Microprocessor complex mediates the genesis of microRNAs , 2004, Nature.

[37]  A. Pasquinelli,et al.  A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.

[38]  M. Daly,et al.  Genetic Mapping in Human Disease , 2008, Science.

[39]  Peter A. Jones,et al.  Epigenetics and MicroRNAs , 2007, Pediatric Research.

[40]  Q. Lu,et al.  Demethylation of CD40LG on the Inactive X in T Cells from Women with Lupus1 , 2007, The Journal of Immunology.

[41]  Fatima Al-Shahrour,et al.  Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. , 2010, Genome research.

[42]  P. Tak,et al.  Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. , 2011, Arthritis and rheumatism.

[43]  J. Pers,et al.  Epigenetics and autoimmunity. , 2010, Journal of autoimmunity.

[44]  R. Gay,et al.  Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. , 2000, Arthritis and rheumatism.

[45]  A. Mutirangura,et al.  Hypomethylation of LINE-1 but not Alu in lymphocyte subsets of systemic lupus erythematosus patients. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[46]  K. Lauber,et al.  The role of defective clearance of apoptotic cells in systemic autoimmunity , 2010, Nature Reviews Rheumatology.

[47]  Mark M. Davis,et al.  miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection , 2007, Cell.

[48]  Xiangpei Li,et al.  Ultraviolet B exposure of peripheral blood mononuclear cells of patients with systemic lupus erythematosus inhibits DNA methylation , 2009, Lupus.

[49]  D. Gutsch,et al.  Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[50]  B. Kahaleh,et al.  Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. , 2006, Arthritis and rheumatism.

[51]  J. Bream,et al.  Cell type-specific regulation of IL-10 expression in inflammation and disease , 2010, Immunologic research.

[52]  W. Filipowicz,et al.  Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.

[53]  Y. Liu,et al.  Decreased DNA methyltransferase levels contribute to abnormal gene expression in "senescent" CD4(+)CD28(-) T cells. , 2009, Clinical immunology.

[54]  J. Lieberman,et al.  A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus , 2007, Journal of Molecular Medicine.

[55]  D. Fox,et al.  Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes. , 1996, Immunology.

[56]  Christopher B Wilson,et al.  Epigenetic control of T-helper-cell differentiation , 2009, Nature Reviews Immunology.

[57]  R. Place,et al.  miR-449a targets HDAC-1 and induces growth arrest in prostate cancer , 2009, Oncogene.

[58]  K. Osawa,et al.  Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. , 2006, Arthritis and rheumatism.

[59]  F. Gao,et al.  Hypomethylation of IL10 and IL13 Promoters in CD4+ T Cells of Patients with Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.

[60]  A. Sawalha,et al.  Impaired T Cell Protein Kinase Cδ Activation Decreases ERK Pathway Signaling in Idiopathic and Hydralazine-Induced Lupus1 , 2007, The Journal of Immunology.

[61]  G. Tsokos,et al.  The Transcriptional Repressor cAMP Response Element Modulator α Interacts with Histone Deacetylase 1 to Repress Promoter Activity1 , 2006, The Journal of Immunology.

[62]  Q. Lu,et al.  Demethylation of the Same Promoter Sequence Increases CD70 Expression in Lupus T Cells and T Cells Treated with Lupus-Inducing Drugs1 , 2005, The Journal of Immunology.

[63]  A. Baccarelli,et al.  The epigenetics of autoimmunity , 2011, Cellular and Molecular Immunology.

[64]  Michael Detmar,et al.  Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[65]  Albert Jeltsch,et al.  Chromatin methylation activity of Dnmt3a and Dnmt3a/3L is guided by interaction of the ADD domain with the histone H3 tail , 2010, Nucleic acids research.

[66]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[67]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[68]  Pierre Youinou,et al.  Epigenetics and autoimmunity, with special emphasis on methylation. , 2011, The Keio journal of medicine.

[69]  M. Petri,et al.  The TNFα locus is altered in monocytes from patients with systemic lupus erythematosus , 2007 .

[70]  G. Tsokos,et al.  Transcriptional regulation of IL-2 in health and autoimmunity. , 2009, Autoimmunity reviews.

[71]  Klaus Rajewsky,et al.  MicroRNA Control in the Immune System: Basic Principles , 2009, Cell.

[72]  H. Ochs,et al.  Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. , 1985, Clinical and experimental immunology.

[73]  H. Moch,et al.  Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. , 2007, Arthritis and rheumatism.

[74]  Jun Yu,et al.  MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer , 2009, British Journal of Cancer.

[75]  T. Dalmay,et al.  The cartilage specific microRNA‐140 targets histone deacetylase 4 in mouse cells , 2006, FEBS letters.

[76]  G. Stephanopoulos,et al.  Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis , 2005, Journal of Neuroimmunology.

[77]  A. Sadovnick,et al.  Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. , 2008, Human molecular genetics.

[78]  Paul Tempst,et al.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex , 1999, Nature Genetics.

[79]  C. Mello,et al.  Revealing the world of RNA interference , 2004, Nature.

[80]  C. Benz,et al.  Rapid alteration of microRNA levels by histone deacetylase inhibition. , 2006, Cancer research.

[81]  G. Tsokos,et al.  Interleukin-17-producing T cells in lupus , 2010, Current opinion in rheumatology.

[82]  C. Mayr,et al.  miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely , 2007, Proceedings of the National Academy of Sciences.

[83]  Yuanjia Tang,et al.  MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1 , 2010, The Journal of Immunology.

[84]  G. Tsokos,et al.  Promoter Hypomethylation Results in Increased Expression of Protein Phosphatase 2A in T Cells from Patients with Systemic Lupus Erythematosus , 2011, The Journal of Immunology.

[85]  M. Vilardell‐Tarrés,et al.  Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus , 2008, Immunology.

[86]  G. Gilkeson,et al.  Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. , 2003, The Journal of clinical investigation.

[87]  Masahiro Yamamura,et al.  Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression. , 2004, Arthritis and rheumatism.

[88]  B. Cairns,et al.  DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45 , 2008, Cell.

[89]  W. Filipowicz,et al.  Repression of protein synthesis by miRNAs: how many mechanisms? , 2007, Trends in cell biology.

[90]  Wei Liu,et al.  A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. , 2009, The Journal of clinical investigation.

[91]  D. Valle,et al.  DNA methylation regulates microRNA expression , 2007, Cancer biology & therapy.

[92]  P. Jagodziński,et al.  Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4+ T cells of patients with systemic lupus erythematosus , 2007, Clinical Rheumatology.

[93]  S. Salah,et al.  Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. , 2011, Clinical and experimental rheumatology.

[94]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[95]  C. Bloomfield,et al.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.

[96]  A. Noor,et al.  Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated , 2007, Journal of neuroscience research.

[97]  R. Voll,et al.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[98]  G. Illei,et al.  MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. , 2011, Arthritis and rheumatism.

[99]  Q. Lu,et al.  Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis , 2009, Scandinavian journal of rheumatology.